MENU
KYMR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kymera Therapeutics (KYMR) Earnings Date & Reports
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives... Show more
A.I. Advisor
published Earnings
KYMR is expected to report earnings to fall 5.30% to -125 cents per share on February 25
Q4'26
Est.
$-1.25
Q3'26
Missed
by $0.06
Q2'26
Beat
by $0.10
Q1'26
Beat
by $0.17
Q4'25
Missed
by $0.18
The last earnings report on October 29 showed earnings per share of -132 cents, missing the estimate of -125 cents. With 727.52K shares outstanding, the current market capitalization sits at 10.57B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics
Industry Biotechnology
Industry
N/A
Address
500 North Beacon Street
Phone
+1 857 285-5300
Employees
238
Web
https://www.kymeratx.com